Pfizer Inc Stock Price on March 4, 2020
PFE Stock | USD 27.81 0.11 0.40% |
Below is the normalized historical share price chart for Pfizer Inc extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pfizer stands at 27.81, as last reported on the 6th of May, with the highest price reaching 27.91 and the lowest price hitting 27.52 during the day.
If you're considering investing in Pfizer Stock, it is important to understand the factors that can impact its price. We consider Pfizer very steady. Pfizer Inc maintains Sharpe Ratio (i.e., Efficiency) of 0.019, which implies the firm had a 0.019% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Pfizer Inc, which you can use to evaluate the volatility of the company. Please check Pfizer's Semi Deviation of 1.32, coefficient of variation of 3037.36, and Risk Adjusted Performance of 0.0269 to confirm if the risk estimate we provide is consistent with the expected return of 0.0297%.
At present, Pfizer's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to 0.00, whereas Other Stockholder Equity is projected to grow to (20.8 B). . At present, Pfizer's Price Earnings Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 22.13, whereas Price Earnings To Growth Ratio is projected to grow to (0.78). Pfizer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of August 2012 | 200 Day MA 30.3014 | 50 Day MA 26.8754 | Beta 0.572 |
Pfizer |
Sharpe Ratio = 0.019
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PFE |
Estimated Market Risk
1.56 actual daily | 13 87% of assets are more volatile |
Expected Return
0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Pfizer is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pfizer by adding it to a well-diversified portfolio.
Price Book 1.6451 | Enterprise Value Ebitda 21.4072 | Price Sales 2.5033 | Shares Float 5.6 B | Dividend Share 1.65 |
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
About Pfizer Stock history
Pfizer investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pfizer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pfizer Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pfizer stock prices may prove useful in developing a viable investing in Pfizer
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 5.7 B | 5.7 B | |
Net Income Applicable To Common Shares | 36.1 B | 37.9 B |
Pfizer Stock Technical Analysis
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pfizer Period Price Range
Pfizer May 6, 2024 Market Strength
Market strength indicators help investors to evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pfizer shares will generate the highest return on investment. By undertsting and applying Pfizer stock market strength indicators, traders can identify Pfizer Inc entry and exit signals to maximize returns
Pfizer Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pfizer's price direction in advance. Along with the technical and fundamental analysis of Pfizer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pfizer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.0269 | |||
Jensen Alpha | (0.02) | |||
Total Risk Alpha | (0.13) | |||
Sortino Ratio | (0.02) | |||
Treynor Ratio | 0.0485 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 1.65 | Earnings Share (0.05) | Revenue Per Share 9.717 | Quarterly Revenue Growth (0.19) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.